brain cancer vaccine

04/17/2012 - 11:52

With help of patient groups, Phase 2 clinica trial paves way for testing therapy that combines cancer vaccine with drug Avastin. A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme—which kills thousands of Americans every year.